Telomere dysfunction in human keratinocytes elicits senescence and a novel transcription profile

Experimental Cell Research

Volumn 314, Issue 13, 2008, Pages 2434-2447

  Minty, Fay ^a,b   Thurlow, Johanna K ^a   Harrison, Paul R ^a   Parkinson, E Kenneth ^b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b Institute of Cell and Molecular Science   (United Kingdom)

Author keywords

DNA damage; Keratinocyte; Microarray; Senescence; Telomere; TRF2

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; COLONY FORMATION; DNA DAMAGE; GENE CONTROL; GENE LOCUS; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE; SENSITIVITY AND SPECIFICITY; TELOMERE;

EID: 47549100990     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.05.007     Document Type: Article

References (70)

1. Jeyapalan J.C., Ferreira M., Sedivy J.M., and Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 128 (2007) 36-44
2. Kim W.Y., and Sharpless N.E. The regulation of INK4/ARF in cancer and aging. Cell 127 (2006) 265-275
3. Ressler S., Bartkova J., Niederegger H., Bartek J., Scharffetter-Kochanek K., Jansen-Durr P., and Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging. Cell 5 (2006) 379-389
4. Martin K., Potten C.S., Roberts S.A., and Kirkwood T.B. Altered stem cell regeneration in irradiated intestinal crypts of senescent mice. J. Cell Sci. 111 Pt 16 (1998) 2297-2303
5. Stern M.M., and Bickenbach J.R. Epidermal stem cells are resistant to cellular aging. Aging. Cell 6 (2007) 439-452
6. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., De Luca M., Catricala C., and O'Toole K.M. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol. 22 (2002) 5157-5172
7. Natarajan E., Omobono II J.D., Guo Z., Hopkinson S., Lazar A.J., Brenn T., Jones J.C., and Rheinwald J.G. A keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence. Am. J. Pathol. 168 (2006) 1821-1837
8. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712
9. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., and Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413 (2001) 432-435
10. Lindsey J., McGill N.I., Lindsey L.A., Green D.K., and Cooke H.J. In vivo loss of telomeric repeats with age in humans. Mutat. Res. 256 (1991) 45-48
11. Kipling D., and Cooke H.J. Hypervariable ultra-long telomeres in mice. Nature 347 (1990) 400-402
12. Luderus M.E., van Steensel B., Chong L., Sibon O.C., Cremers F.F., and de Lange T. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex. J. Cell Biol. 135 (1996) 867-881
13. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
14. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., and de Lange T. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
15. Li G.Z., Eller M.S., Firoozabadi R., and Gilchrest B.A. Evidence that exposure of the telomere 3′ overhang sequence induces senescence. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 527-531
16. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
17. Smogorzewska A., and de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21 (2002) 4338-4348
18. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
19. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
20. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., et al. The RNA component of human telomerase. Science 269 (1995) 1236-1241
21. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
22. Holt S.E., Wright W.E., and Shay J.W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol. 16 (1996) 2932-2939
23. Masutomi K., Yu E.Y., Khurts S., BenPorath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., and Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 114 (2003) 241-253
24. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 (2003) 1549-1556
25. van Steensel B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
26. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
27. Karlseder J., Broccoli D., Dai Y., Hardy S., and de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283 (1999) 1321-1325
28. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., and Barrett J.C. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 6 (2004) 168-170
29. Muntoni A., Fleming J., Gordon K.E., Hunter K., McGregor F., Parkinson E.K., and Harrison P.R. Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-beta: but p53 mutations are not necessarily required. Oncogene 22 (2003) 7804-7808
30. Allen-Hoffmann B.L., and Rheinwald J.G. Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 7802-7806
31. Edington K.G., Loughran O.P., Berry I.J., and Parkinson E.K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol. Carcinog. 13 (1995) 254-265
32. Munro J., Steeghs K., Morrison V., Ireland H., and Parkinson E.K. Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres. Oncogene 20 (2001) 3541-3552
33. McGregor F., Muntoni A., Fleming J., Brown J., Felix D.H., MacDonald D.G., Parkinson E.K., and Harrison P.R. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res. 62 (2002) 4757-4766
34. Levy L., Broad S., Zhu A.J., Carroll J.M., Khazaal I., Peault B., and Watt F.M. Optimised retroviral infection of human epidermal keratinocytes: long-term expression of transduced integrin gene following grafting on to SCID mice. Gene Ther. 5 (1998) 913-922
35. Li B., Oestreich S., and de Lange T. Identification of human Rap1: implications for telomere evolution. Cell 101 (2000) 471-483
36. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (Oxford, England) 19 (2003) 185-193
37. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31 (2003) e15
38. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S.A. 98 (2001) 5116-5121
39. Ihaka R., and Gentleman R.R. A language for data analysis and graphics. J. Comp. Graphical. Stat. 5 (1996) 299-314
40. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
41. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9363-9367
42. Robles S.J., and Adami G.R. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16 (1998) 1113-1123
43. Rheinwald J.G. Serial cultivation of normal human epidermal keratinocytes. Methods Cell Biol. 21A (1980) 229-254
44. Lobrich M., Ikpeme S., and Kiefer J. Measurement of DNA double-strand breaks in mammalian cells by pulsed-field gel electrophoresis: a new approach using rarely cutting restriction enzymes. Radiat. Res. 138 (1994) 186-192
45. Jacobs J.J., and de Lange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14 (2004) 2302-2308
46. Dickson M.A., Hahn W.C., Ino Y., Ronfard V., Wu J.Y., Weinberg R.A., Louis D.N., Li F.P., and Rheinwald J.G. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20 (2000) 1436-1447
47. Loughran O., Malliri A., Owens D., Gallimore P.H., Stanley M.A., Ozanne B., Frame M.C., and Parkinson E.K. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 13 (1996) 561-568
48. Ramirez R.D., Morales C.P., Herbert B.S., Rohde J.M., Passons C., Shay J.W., and Wright W.E. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15 (2001) 398-403
49. Darbro B.W., Schneider G.B., and Klingelhutz A.J. Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes. J. Invest. Dermatol. 125 (2005) 499-509
50. Kang M.K., Kameta A., Shin K.H., Baluda M.A., Kim H.R., and Park N.H. Senescence-associated genes in normal human oral keratinocytes. Exp. Cell Res. 287 (2003) 272-281
51. Smogorzewska A., Karlseder J., Holtgreve-Grez H., Jauch A., and de Lange T. DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr. Biol. 12 (2002) 1635-1644
52. Benanti J.A., and Galloway D.A. Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24 (2004) 2842-2852
53. Taylor R.S., Ramirez R.D., Ogoshi M., Chaffins M., Piatyszek M.A., and Shay J.W. Detection of telomerase activity in malignant and nonmalignant skin conditions. J. Investi. Dermatol. 106 (1996) 759-765
54. Jung D., Giallourakis C., Mostoslavsky R., and Alt F.W. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 24 (2006) 541-570
55. Barrandon Y., and Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 2302-2306
56. Kang M.K., Bibb C., Baluda M.A., Rey O., and Park N.H. In vitro replication and differentiation of normal human oral keratinocytes. Exp. Cell Res. 258 (2000) 288-297
57. Simbulan-Rosenthal C.M., Trabosh V., Velarde A., Chou F.P., Daher A., Tenzin F., Tokino T., and Rosenthal D.S. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation. Oncogene 24 (2005) 5443-5458
58. Alani R.M., Hasskarl J., Grace M., Hernandez M.C., Israel M.A., and Munger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Nat. Acad. Sci. U. S. A. 96 (1999) 9637-9641
59. Franco S., Canela A., Klatt P., and Blasco M.A. Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models. Carcinogenesis 26 (2005) 1613-1626
60. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., Lee H.W., von Zglinicki T., Ganser A., Schirmacher P., Nakauchi H., and Rudolph K.L. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 39 (2007) 99-105
61. Chen F., Kook H., Milewski R., Gitler A.D., Lu M.M., Li J., Nazarian R., Schnepp R., Jen K., Biben C., Runke G., Mackay J.P., Novotny J., Schwartz R.J., Harvey R.P., Mullins M.C., and Epstein J.A. Hop is an unusual homeobox gene that modulates cardiac development. Cell 110 (2002) 713-723
62. Chen Y., Petersen S., Pacyna-Gengelbach M., Pietas A., and Petersen I. Identification of a novel homeobox-containing gene, LAGY, which is downregulated in lung cancer. Oncology 64 (2003) 450-458
63. Lemaire F., Millon R., Muller D., Rabouel Y., Bracco L., Abecassis J., and Wasylyk B. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. Br. J. Cancer 91 (2004) 258-261
64. Hunter K.D., Thurlow J.K., Fleming J., Drake P.J., Vass J.K., Kalna G., Higham D.J., Herzyk P., Macdonald D.G., Parkinson E.K., and Harrison P.R. Divergent routes to oral cancer. Cancer Res. 66 (2006) 7405-7413
65. Kook H., Lepore J.J., Gitler A.D., Lu M.M., Wing-Man Yung W., Mackay J., Zhou R., Ferrari V., Gruber P., and Epstein J.A. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112 (2003) 863-871
66. Humke E.W., Shriver S.K., Starovasnik M.A., Fairbrother W.J., and Dixit V.M. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103 (2000) 99-111
67. Wang Y., Hasegawa M., Imamura R., Kinoshita T., Kondo C., Konaka K., and Suda T. PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase1. Int. Immunol. 16 (2004) 777-786
68. Severa M., Coccia E.M., and Fitzgerald K.A. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J. Biol. Chem. 281 (2006) 26188-26195
69. Sprangers M., Feldhahn N., Liedtke S., Jumaa H., Siebert R., and Muschen M. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells. Oncogene 25 (2006) 5180-5186
70. Kook H., Yung W.W., Simpson R.J., Kee H.J., Shin S., Lowry J.A., Loughlin F.E., Yin Z., Epstein J.A., and Mackay J.P. Analysis of the structure and function of the transcriptional coregulator HOP. Biochemistry 45 (2006) 10584-10590